600713.SS Overview

Company Profile

Nanjing Pharmaceutical Group Company Limited engages in the distribution of pharmaceuticals, medical devices, and health products in China. It also involved in the wholesale and retail of pharmaceuticals; provision of internet + Chinese medicine pharmacy service platform; and pharmaceutical third-party logistics services. The company was formerly known as NanJing Pharmaceutical Company Limited and change its name to Nanjing Pharmaceutical Group Company Limited in December 2025. Nanjing Pharmaceutical Group Company Limited was founded in 1951 and is based in Nanjing, China.

Related stocks

600771.SS

600771.SS • China

GUANGYUYUAN CHINESE HERBAL MEDI

14.38 CNY

1.05B USD 1Y -24.5%

300181.SZ

300181.SZ • China

13.25 CNY

1.39B USD 1Y -25.8%

300357.SZ

300357.SZ • China

19.99 CNY

1.57B USD 1Y -30.7%

002019.SZ

002019.SZ • China

9.66 CNY

1.76B USD 1Y -30.7%

SANOFICONR.NS

SANOFICONR.NS • India

SANOFI CONS HEALTHC IND L

3,581.7 INR

853.55M USD 1Y -24.8%

SANOFI.BO

SANOFI.BO • India

SANOFI INDIA LTD

2,945.55 INR

700.95M USD 1Y -37%

PFIZER.NS

PFIZER.NS • India

3,808.2 INR

1.8B USD 1Y -27.7%

H02.SI

H02.SI • Singapore

12.77 SGD

2.21B USD 1Y -13.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

5 Metrics

Country

Region

Sector

Industry

Drug Manufacturers - General

Website

https://www.njyy.com

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

28.3% p.a.

Max Drawdown (5Y)

-36.9%

Sharpe Ratio (5Y)

-0.01

Beta Factor

0.20

Size Class

Mid Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (28.3% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -56.6% in the extended horizon.